U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896109) titled 'A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894133) titled 'Gait Parameters in Breast Cancer Receiving Chemotherapy Patients' on Oct. 13. Brief Summar... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896161) titled 'Evaluation of a DRG-Based Clinical Management Model in a High-Complexity Chilean Hospital' ... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894250) titled 'Q-Angle, Segment Length, Quadriceps, and Knee Alignment in Soccer Players' on Oct. 14. Bri... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894367) titled 'Gematinib Combined With Lenvatinib for the Treatment of Locally Advanced or Metastatic Non-... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895940) titled 'Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitati... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894068) titled 'IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Contro... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinatio... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894952) titled 'Implementing IVM for Fertility Treatment in Clinical Practice' on Oct. 07. Brief Summary: ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients ... Read More